Metformin-letrozole in comparison with Metformin-clomiphene citrate in clomiphene-resistance PCOS patients undergoing IUI [PDF]
Iranian Journal of Reproductive Medicine, 2011 Background: Polycystic ovary syndrome (PCOS) is associated with approximately 75% of women who suffer from infertility due to anovulation. Additionally, around 20– 25% of anovulatory women with PCOS do not respond at all to clomiphene citrate and are ...
Mohammad Hossein Fallahzadeh +2 more
doaj +1 more source
Endometrial Thinning after Ovarian Stimulation using Letrozole or Clomiphene Citrate: A Randomized Trial [PDF]
Siriraj Medical Journal, 2018 Objective: To compare endometrial thickness after three consecutive cycles of ovulation induction with clomiphene citrate versus letrozole. Methods: Eighty-four women with normal menstrual interval who attended the university infertility clinic from June
Roungsin Choavaratana +6 more
doaj +4 more sources
Letrozole or clomiphene citrate as first line for anovulatory infertility: a debate [PDF]
Reproductive Biology and Endocrinology, 2011 Clomiphene citrate has been traditionally used as the drug of choice in treating women with anovulatory infertility. In the last decade letrozole, an aromatase inhibitor has emerged as alternative ovulation induction agent.
George Korula, Kamath Mohan S
doaj +2 more sources
Melanoma Cells Exposed to Clomiphene Citrate Respond With Cell Cycle Arrest and Reduced Invasiveness. [PDF]
J Appl ToxicolABSTRACT Epidemiological studies have suggested that clomiphene citrate (CC) exposure may increase the risk of malignant melanoma, but mechanisms are unknown. We investigated the effects of CC on melanoma cell line A375. Cells were treated with CC at 2, 20, 200, and 2000 ng/mL, followed by assessment of cell viability and metabolism, cell cycle ...
Ribeiro TS +8 more
europepmc +2 more sources
Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. [PDF]
, 2009 To assess long-term health effects of ovarian-stimulation drugs we followed-up for over 20 years a British cohort of 7355 women with ovulatory disorders, 43% of whom were prescribed ovarian-stimulation drugs, and identified a total of 274 deaths and 367 ...
Overton, C +30 more
core +1 more source
Effect of Ubiquinol supplementation on ovulation induction in Clomiphene Citrate resistance
Middle East Fertility Society Journal, 2021 Background Clomiphene Citrate is considered the gold-standard for induction of ovulation and has been used for several years to treat PCOS related infertility. Unfortunately, 15-40% of women with PCOS are resistant to Clomiphene Citrate.
Islam Mohamed Magdi Ammar +1 more
doaj +1 more source
Medical Sciences, 2019 Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility in women of reproductive age. Lifestyle change is considered the first line treatment for the management of infertile anovulatory women with PCOS, and weight loss for ...
Michael Costello +12 more
doaj +1 more source
FERTILITY IN RAMS TREATED WITH CLOMIPHENE CITRATE [PDF]
Assiut Veterinary Medical Journal, 1998 The effect of orally administered clomiphene citrate on the fertility of rams was studied. Semen and blood samples were collected from a five mature and fertile Rahmani rams (control) twice per week for 3 weeks. Each ram was treated with 100mg-clomiphene
W.M.B. Noseir
doaj +1 more source
Clomiphene citrate: the changing landscape [PDF]
, 2018 Ovulatory dysfunction is one of the leading causes of female infertility. Clomiphene citrate has emerged as a boon in the induction of ovulation in the human female.
Khanna, Jyoti, Gupta, Mahesh C.
core +1 more source
Letrozole vs. Clomiphene Citrate for Infertility in Polycystic Ovarian Syndrome [PDF]
, 2018 Purpose To determine if letrozole is an equal or better alternative to clomiphene citrate for infertility treatment in PCOS patients. Literature Review Letrozole was found to have higher ovulation rates, fewer twin pregnancies/more single births, higher ...
Potratz, Kailey
core +3 more sources